Faculty Directory

Steven Gillis

Adjunct Professor of Business Administration

E-Mailsgillis@archventure.com

Phone206-674-3278

DegreePhD, Dartmouth College, 1978; BA, Williams College, 1975

AREAS OF EXPERTISEBiotechnology, vaccines and antibody-based therapeutics

Current Research Topics

  • Molecular and tumor immunology

Awards

  • International Immunopharmacology Award, 1983
  • Conant-Harrington Prize for Outstanding Research in Biology, 1976

Professional Activities

Academic positions

  • Tuck School, 2012–present
  • Adjunct Professor of Community and Family Medicine, Dartmouth Medical School, 2009–present
  • Adjunct Professor of Business Administration, Tuck School, 2011
  • Adjunct Professor, 1990–98, Adjunct Associate Professor, 1983–90, Assistant Professor, 1980–83, University of Washington

Nonacademic positions

  • Managing Director, ARCH Venture Partners, 2005–present
  • Founder and Director, Corixa Corporation, 1994–2005
  • Founder and Director, Immunex Corporation, 1981–98

Board memberships

  • Director, Accelerator Corporation, Allozyne, VBI Vaccines, Groove Pharmaceuticals, Acylin Corporation, PhaseRx, Pulmatrix, VentiRx Pharmaceuticals, Theraclone Sciences, Lycera, and VLST Corporation
  • Board of Overseers, Dartmouth Medical School
  • Board of Advisors, Norris Cotton Cancer Center
  • Discovery Investment Board, GlaxoSmithKline
  • Board of Advisors, The W Fund

Editorial positions

  • Editor-in-Chief, Lymphokine Research, 1982–83
  • Editor, Biotechnology Therapeutics, 1989–93
  • Associate Editor, Journal of Cellular and Molecular Immunology, 1984–94
  • Lymphokine Research, 1983–85, Journal of Biological Response Modifiers, 1982–89, Journal of Immunology, 1980–83
  • Editorial Board, Therapeutic Immunology, 1992–99, Journal of Clinical Immunology, 1990–2000, Journal of Immunotherapy, 1989–2001, Molecular Biotherapy, 1988–92, Journal of Cellular Immunology, 1984–94
  • Editorial Advisory Board, Cytokine, 1990–present